Yale Precision Medicine Tumor Board: reawakening the guardian of the genome

Lancet Oncol. 2022 Mar;23(3):337-338. doi: 10.1016/S1470-2045(22)00037-7.

Authors

Michael J Grant¹, Karin E Finberg², Zenta Walther², Stacey M Stein¹, Jill Lacy¹, Joseph P Eder¹, Sarah B Goldberg³

Affiliations

¹ Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
² Department of Pathology, Yale School of Medicine, New Haven, CT 06510, USA.
³ Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: [email protected].

PMID: 35240081
DOI: 10.1016/S1470-2045(22)00037-7

No abstract available

MeSH terms

Genome
Humans
Molecular Targeted Therapy
Neoplasms* / genetics
Neoplasms* / pathology
Neoplasms* / therapy
Precision Medicine*